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angerhans  cell  histiocytosis  (LCH)  is  characterized  by  clonal
roliferation  of  Langerhans  cells  exhibiting  Birbeck  granules
nd  positive  immunohistochemistry  for  S100  and  CD1A.1 A
alignant  transformation  or  a  functional  proliferation  of
angerhans  cells  responding  to  external  stimuli  are  possible
ources.2 In  the  oral  cavity,  they  can  occasionally  present  as
yperplasia  of  the  gingiva  or  ulcers  of  the  cheek,  palate,
r  tongue  mucosa.3 The  diagnosis  is  made  after  careful
xamination,  and  the  exclusion  of  other  similar  diagnostic
ossibilities.
Several  therapeutic  modalities  have  been  suggested
or  LCH,  such  as  intralesional  corticosteroid  injection,
ntibiotics,  steroids,  radiation  therapy,  and  chemotherapy.
urgical  options  ranging  from  extensive  resections  to  more
onservative  approaches  are  available  and,  in  many  cases,
ealing  has  resulted  from  a  single  biopsy.4
The  present  report  regards  LCH  in  the  oral  cavity  and
mphasizes  the  rarity  of  this  lesion,  as  well  as  the  impor-
ance  of  differential  diagnosis,  treatment,  and  appropriate
ollow-up  for  these  patients.
 Please cite this article as: Lima EN, de Araújo EM, de Oliveira PT,
e Medeiros AM. Oral Langerhans cell histiocytosis: case report with
ollow-up of ten years. Braz J Otorhinolaryngol. 2014;80:366--7.
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eserved.ase presentation
 ten-year-old  male  with  leukoderma  presented  to  the
tomatology  Clinic,  with  a three-month  history  of  a  lesion
n  the  roof  of  the  mouth.  On  intraoral  examination,  a
ed  ulcerated  lesion  of  approximately  1  cm  size  with  an
rthodontic  ring  (Fig.  1A)  was  seen  on  the  palatal  gingiva
djacent  to  the  ﬁrst  upper  molar.  Following  periodontal
reatment,  no  improvement  was  observed,  and  an  initial
iagnosis  of  paracoccidioidomycosis  was  suggested.  Inci-
ional  biopsy  revealed  a  lesion  predominantly  consisting
f  polygonal  cells,  at  times  exhibiting  granular  cytoplasm
Fig.  1B),  consistent  with  LCH  and  conﬁrmed  by  strongly
ositive  immunohistochemistry  for  S100  (Fig.  1C)  and  CD1A
Fig.  1D).  The  condition  was  treated  by  chemotherapy  and
urgical  removal  of  the  lesion.  Over  the  next  ten  years,  the
atient  was  assessed  twice  a  year,  and  showed  no  clinical
igns  of  relapse.  On  his  last  visit,  he  underwent  a  bone  scan
nd  temporal  bone  computed  tomography  and  there  was  no
vidence  of  relapse  or  metastases.
iscussion
he  etiopathogenesis  of  LCH  has  not  been  fully  determined,
nd  a  possible  reaction  or  neoplastic  phenomena  has  been
roposed.  A  few  authors  further  suggest  an  immune  system
egulation  disorder  and  a  familial  predisposition,5 since  it
requently  affects  children,  as  in  the  present  report.
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Figure  1  (A)  Intraoral  clinical  imaging  showing  red  ulcerated  lesion  in  the  palatal  gingiva,  adjacent  to  the  ﬁrst  upper  molar.  (B)
Microphotograph  showing  neoplastic  lesion  characterized  by  polygonal  cells,  at  times  exhibiting  granular  cytoplasm  among  numerous
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cytosis in four-month-old child. Int J Pediatr Otorhinolaryngol.
2011;75:963--7.blood vessels,  and  inﬂammatory  inﬁltrate  consisting  of  lymphocy
ical ﬁndings  positive  for  S100  (×200).  (D)  Immunohistochemical
The  clinical  features  of  LCH  are  similar  to  several  con-
ditions,  including  periodontal  disease,  malignancies  such  as
squamous  cell  carcinoma  or  lymphoma,  as  well  as  granulo-
matous  or  ulcerative  lesions  that  are  characteristic  of  fungal
infections.2 Thus,  a  thorough  assessment  is  appropriate  for
oral  cavity  lesions  that  persist  after  treatment.  In  the  oral
cavity,  it  usually  presents  as  a  mucosal  ulcer  associated  with
underlying  bone  lesions,6 which  was  not  observed  in  this
case.
Diagnosis  may  be  conﬁrmed  by  detecting  the  charac-
teristic  Birbeck  granules  (X  bodies)  or  speciﬁc  monoclonal
antibodies  to  surface  antigens  (CD1).6 In  the  present  case,
diagnosis  was  conﬁrmed  after  an  immunohistochemical
study  that  characterized  the  proliferating  cell  type.
The  therapeutic  approach  depends  on  the  extent  of  the
disease  and  local  treatment  is  usually  effective  in  forms
limited  to  a  single  organ.  However,  a  few  complications,
such  as  pituitary  gland  malfunction,  and  especially  diabetes
and  neurodegenerative  diseases  can  occur.5 A  retrospective
review  of  patients  with  LCH  revealed  a  high  ten-year  survival
rate  (93%);  most  individuals  are  low-risk  and  have  no  bone
marrow,  spleen,  liver,  or  lung  involvement.1 Our  patient
has  had  no  relapse  or  metastasis  after  a  ten-year  follow-
up;  however,  long-term  follow-up  is  required  to  detect  and
control  possible  late-onset  sequelae.3Final comments
The  present  report  discussed  clinical  and  laboratory  infor-
mation  on  LCH,  emphasizing  the  importance  of  differential
6 neutrophils,  and  eosinophils  (HE  ×400).  (C)  Immunohistochem-
ings  positive  for  CD1A  (×400).
iagnosis,  appropriate  treatment,  and  long-term  follow-up
ith  complication  and/or  relapse  prevention.
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